Dan Liao
- Cancer Research top 2%
- Oncology top 5%
- Peptidase Inhibition and Analysis 3
- Molecular Biology top 5%
- Cancer-related gene regulation 8
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 6
- RNA Research and Splicing 6
- Ubiquitin and proteasome pathways 5
- Extracellular vesicles in disease 3
- Protein Degradation and Inhibitors 3
- Immunology top 10%
- Co-authors
- Tiebang KangRuhua ZhangLi ZhongXin WangYue XingMan‐Li LuoFengxi SuDi Huang
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Dan Liao
34 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 753
- Oncology 833
- Molecular Biology 1.4k
- Immunology 374
- Pulmonary and Respiratory Medicine 262
Countries citing papers authored by Dan Liao
This map shows the geographic impact of Dan Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Liao more than expected).
Fields of papers citing papers by Dan Liao
This network shows the impact of papers produced by Dan Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Liao. The network helps show where Dan Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 73 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 47 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 110 | |
| 10 | 2020 | 12 | |
| 11 | 2019 | 56 | |
| 12 | 2019 | 6 | |
| 13 | 2018 | 17 | |
| 14 | 2018 | 5 | |
| 15 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemnessbreakdown → | 2018 | 921 |
| 16 | 2017 | 40 | |
| 17 | 2016 | 69 | |
| 18 | 2015 | 101 | |
| 19 | 2014 | 24 | |
| 20 | 2008 | 2 |
About Dan Liao
Dan Liao is a scholar working on Molecular Medicine, Molecular Biology and Oncology, having authored 35 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (6 papers), Ubiquitin and proteasome pathways (5 papers), Extracellular vesicles in disease (3 papers), Protein Degradation and Inhibitors (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (753 citations), Oncology (833 citations) and Molecular Biology (1.4k citations). Dan Liao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Tiebang Kang, Ruhua Zhang, Li Zhong, Xin Wang, Yue Xing, Man‐Li Luo, Fengxi Su, Di Huang, Linbin Yang and Fei Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.